Nonmelanoma skin cancer and risk for subsequent malignancy

Journal of the National Cancer Institute

Volumn 100, Issue 17, 2008, Pages 1215-1222

  Chen, Jiping ^a   Ruczinski, Ingo ^b   Jorgensen, Timothy J ^b,c   Yenokyan, Gayane ^b   Yao, Yin ^b   Alani, Rhoda ^d   Liégeois, Nanette J ^d   Hoffman, Sandra C ^b,e   Hoffman Bolton, Judith ^b,e   Strickland, Paul T ^b   Helzlsouer, Kathy J ^b,e,f   Alberg, Anthony J ^b,e,g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e George W Comstock Center for Public Health Research and Prevention   (United States)

^f MERCY MEDICAL CENTER   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BODY MASS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; COVARIANCE; EDUCATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SEX; SKIN CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; TIME; UNITED STATES;

ADULT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; MALE; MARYLAND; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS;

EID: 51749111664     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn260     Document Type: Article

References (35)

1. American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society; 2007.
2. Scotto J, Fears TR, Kraemer KH, Fraumeni JF Jr. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Chapter 60, 2nd ed. New York: Oxford University Press; 1996.
3. Chen JG, Fleischer AB, Smith ED, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035-1038.
4. Scotto J, Fears TR, Fraumeni JF Jr. Solar radiation. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Chapter 17, 2nd ed. New York: Oxford University Press;1996.
5. Habif TP. Clinical Dermatology. In: Habif TP, ed. Premalignant and Malignant Nonmelanoma Skin Tumors. Chapter 21, 4th ed. Philadelphia, PA: Mosby; 2004.
6. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136(12):1524- 1530.
7. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327(7418):794-798.
8. Graells J. The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population. J Eur Acad Dermatol Venereol. 2004;18(2):142-147.
9. Karagas MR, Stukel TA, Greenberg ER, Baron JA, Mott LA, Stern RS. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA. 1992;267(24):3305-3310.
10. Lovatt TJ, Lear JT, Bastrilles J, et al. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol. 2005;52(3):468-473.
11. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med. 1996;125(10):815-821.
12. Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control. 2000;11(10):891-897.
13. Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol. 2000;136(5):647-651.
14. Milan T, Pukkala E, Verkasalo PK, et al. Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer. 2000;87(2):283-288.
15. Rosenberg CA, Khandekar J, Greenland P, Rodabough RJ, McTiernan A. Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study. Cancer. 2006;106(3):654-663.
16. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol. 1995;141(10):916-922.
17. Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarker Prev. 1998;7(2):157-161.
18. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer. 1999;80(4):511-515.
19. Troyanova P, Danon S, Ivanova T. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma. 2002;49(2):81-85.
20. Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM. Association of nonmelanoma skin cancer with second malignancy. Cancer. 2004;100(1):130-138.
21. Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarker Prev. 2005;14(11):2584-2590.
22. Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA. 1998;280(10):910-912.
23. Hjalgrim H, Frisch M, Storm HH, Glimelius B, Pedersen JB, Melbye M. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Int J Cancer. 2000;85(5):639-642.
24. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995;142(12):1255-1264.
25. Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York: Wiley; 1987.
26. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91(234):473-489.
27. Schafer JL. Analysis of incomplete multivariate data. London: Chapman & Hall; 1997.
28. Dai J, Ruczinski I, LeBlanc M, Kooperberg C. Imputation methods to improve inference in SNP association studies. Genetic Epidemiol. 2006;30(8):690-702.
29. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residual. Biometrika. 1994;81(3):515-526.
30. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol. 2005;32(3):191-205.
31. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis. 2005;26(10):1657-1667.
32. Daya-Grosjean L, Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res. 2005(1-2);43-56.
33. Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer KJ. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1271-1275.
34. Gerlini G, Romagnoli P, Pimpinelli N. Skin cancer and immunosuppression. Crit Rev Oncol Hematol. 2005;56(1):127-136.
35. Lu H, Ouyang W, Huang C. Infl ammation, a key event in cancer development. Mol Cancer Res. 2006;4(4):221-233.